IMR Press / FBE / Special Issues / tumor_viruses

Tumor Viruses and Their Associated Cancers: What is in the Pipeline?

Submission deadline: 31 December 2022
Special Issue Editor
  • Sherif T.S. Hassan, PhD
    Czech University of Life Sciences Prague, Prague, Czechia
    Interests: infectious diseases; pharmacology and toxicology; molecular medicine; natural products; analytical and bioanalytical techniques
Special Issue Information

Dear Colleagues,

Viruses are contagious agents made up of a piece of genetic material, such as DNA or RNA, that are enclosed in a coat of protein, with the ability to infect a variety of living organisms. Viruses can infect humans and animals, causing serious diseases. Following studies in 1911 on the Rous sarcoma virus (RSV), a retrovirus that causes cancer in chickens, the field of tumor virology has expanded worldwide, with the information that certain types of DNA and RNA viruses, known as tumor viruses or oncogenic viruses, can lead to cancer. Extensive studies have been performed on tumor viruses and their linked malignancies, leading to important findings on managing infections with tumor viruses and their associated cancers. This Special Issue aims to collect recent investigations on tumor viruses and their resultant cancers. We encourage the submission of original research articles, including preclinical and clinical studies, and reviews that make a novel and substantial contribution to the scientific community.

Dr. Sherif T.S. Hassan

Guest Editor

Keywords
tumor viruses
DNA viruses
RNA viruses
cancer
diagnosis/treatment and prevention methodologies
drug design and development
molecular and physiologic investigations
cellular and genetic studies
disease pathogenesis
computational studies
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 500 USD. Submitted manuscripts should be well formatted in good English.

Back to top